Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study

American Heart Journal

Volumn 154, Issue 5, 2007, Pages 969-975

  Horne, Benjamin D ^a   Carlquist, John F ^a,b   Muhlestein, Joseph B ^a,b   Nicholas, Zachary P ^a   Anderson, Jeffrey L ^a,b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CORONARY ANGIOGRAPHY; DNA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME; GENOME, HUMAN; GENOTYPE; HEART CATHETERIZATION; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PREVALENCE;

EID: 35448956156     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.032     Document Type: Article

References (31)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 15-26
2. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
3. Nora J.J., Lortscher R.H., Spangler R.D., et al. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 61 (1980) 503-508
4. Barrett-Connor E., and Khaw K.T. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 69 (1984) 1065-1069
5. Marenberg M.E., Risch N., Berkman L.F., et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
6. Horne B.D., Camp N.J., Muhlestein J.B., et al. Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 152 (2006) 305-311
7. Pajukanta P., Terwilliger J.D., Perola M., et al. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels. Am J Hum Genet 64 (1999) 1453-1463
8. Shearman A.M., Ordovas J.M., Cupples L.A., et al. Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32,3-qter: a genome-wide scan in the Framingham Study. Hum Mol Genet 9 (2000) 1315-1320
9. Coon H., Leppert M.F., Eckfeldt J.H., et al. Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) blood pressure study. Arterioscler Thromb Vasc Biol 21 (2001) 1969-1976
10. Klos K.L., Kardia S.L., Ferrell R.E., et al. Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler Thromb Vasc Biol 21 (2001) 971-978
11. Peacock J.M., Arnett D.K., Atwood L.D., et al., on behalf of the Investigators of the NHLBI Family Heart Study. Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 21 (2001) 1823-1828
12. Soro A., Pajukanta P., Lilja H.E., et al. Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families. Am J Hum Genet 70 (2002) 1333-1340
13. Ludwig E., Corneli P.S., Anderson J.L., et al. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 91 (1995) 2120-2124
14. Anderson J.L., Carlquist J.F., King G.J., et al. Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women. J Am Coll Cardiol 31 (1998) 790-796
15. Keavney B., McKenzie C., Parish S., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 355 (2000) 434-442
16. Pajukanta P., Cargill M., Viitanen L., et al. Two loci on chromosomes 2 and X for premature coronary heart disease identified in early and late-settlement populations of Finland. Am J Hum Genet 67 (2000) 1481-1493
17. Broeckel U., Hengstenberg C., Mayer B., et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 30 (2002) 210-214
18. Harrap S.B., Zammit K.S., Wong Z.Y., et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler Thromb Vasc Biol 22 (2002) 874-878
19. Wang L., Fan C., Topol S.E., et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302 (2003) 1578-1581
20. Hauser E.R., Crossman D.C., Granger C.B., et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet 75 (2004) 436-447
21. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 (2004) 233-239
22. Wang Q., Rao S., Shen G.Q., et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet 74 (2004) 262-271
23. Shiffman D., Ellis S.G., Rowland C.M., et al. Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 77 (2005) 596-605
24. Hopkins P.N., Hunt S.C., and Wu L.L. Family history and genetic factors. In: Wong N.D., Black H.R., and Gardin J.M. (Eds). Preventive cardiology, a practical approach (2005), McGraw-Hill, New York 92-148
25. Anderson J.L., Carlquist J.F., Horne B.D., et al. Cardiovascular pharmacogenomics: current status, future prospects. J Cardiovasc Pharmacol Ther 8 (2003) 71-83
26. Skol A.D., Scott L.J., Abecasis G.R., et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 (2006) 209-213
27. Camp N.J., Swensen J., Horne B.D., et al. Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genet Epidemiol 28 (2005) 232-243
28. Topol E.J., Smith J., Plow E.F., et al. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15 (2006) R117-R123
29. Bauerfeind A., Knoblauch H., Costanza M.C., et al. Concordant association of lipid gene variation with a combined HDL/LDL-cholesterol phenotype in two European populations. Hum Hered 61 (2006) 123-131
30. Whiting B.M., Anderson J.L., Muhlestein J.B., et al. Candidate gene susceptibility variants predict intermediate endpoints but not angiographic coronary artery disease. Am Heart J 150 (2005) 243-250
31. Horne B.D., Anderson J.L., Carlquist J.F., et al. Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet 69 (2005) 176-186